Humanigen, Inc. (HGEN) stock Continues to Gain today: Things you Need to Know
ST Staff
March 29, 2021
Humanigen, Inc. (HGEN) announced positive phase 3 Topline results of lenzilumab, humanized monoclonal antibody, after which the HGEN stock price saw a surge of 45.42%